美国癌症协会近日发布了迄今为止最为具体的前列腺癌筛查指南,标志着该机构在筛查策略上的一次重大政策逆转 468。新指南不再仅依赖个体化风险评估,而是向平均风险和高风险的老年男性提出了明确的“常规筛查”建议,推荐通过血液检测来早期发现前列腺癌 12578。这一举措旨在提高疾病的早期检出率,从而改善患者的预后 14。
根据最新建议,处于平均风险等级的男性应在50岁至69岁之间,每两年进行一次前列腺特异性抗原(PSA)血液检测 6。对于被视为高风险的群体,包括黑人男性以及有特定家族史的人群,检测频率和起始年龄有所调整 6。具体而言,因种族或家族史被视为高风险的男性应从45岁开始每年接受一次PSA检测 6。若近亲在65岁之前确诊前列腺癌或有多个亲属患病,同样适用45岁起每年检测的标准;若仅有一名近亲在65岁及以上确诊,则建议从45岁开始每两年检测一次 6。
此次指南更新的背景凸显了前列腺癌筛查的紧迫性,特别是在华盛顿特区等地,前列腺癌死亡率长期位居全美前列 15。媒体指出,这一变化扭转了过去的指导方针,为大多数老年男性提供了更清晰的行动指南 25。多家主流媒体均报道了这一重要卫生政策调整 235678。
The American Cancer Society (ACS) has released updated guidelines urging routine prostate cancer screening for most older men, marking a significant shift toward clearer recommendations for regular blood tests 12. This new policy is described as the society’s most specific guidance to date, designed to encourage earlier detection and improve patient outcomes through consistent monitoring of average- and high-risk populations 47. The update represents a notable reversal from previous strategies that relied more heavily on individualized risk assessment, now explicitly advocating for standardized testing protocols 58.
Under the new framework, men with an average risk are advised to undergo PSA (prostate-specific antigen) blood tests every two years between the ages of 50 and 69 6. High-risk groups, including Black men and those with a family history of the disease, are recommended to begin annual screenings at age 45 6. Specifically, men whose close relatives were diagnosed before age 65 or who have multiple affected relatives should test annually starting at 45, while those with only one relative diagnosed at 65 or older may follow a biennial schedule beginning at 45 6. The urgency of these measures is underscored by data indicating that Washington, D.C., currently holds the highest prostate cancer mortality rate in the United States, highlighting the critical need for early intervention 15.
评论
还没有评论,欢迎留下第一条。